Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2022-10-28 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2022
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the transcript of a conference call with analysts and investors on the financial results for the quarter and half year ended 30th September 2022. It states that the transcript has been placed on the company's website and is not the transcript itself. The document length is short (1526 characters), and it serves as an announcement or notification rather than the full transcript. According to the rules, such announcements about the availability of transcripts should be classified as Regulatory Filings (RNS) because it is a regulatory announcement and not the full call transcript itself.
2022-10-28 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the transcript of a conference call with analysts and investors on the financial results for the quarter and half year ended 30th September 2022. It states that the transcript has been placed on the company's website and is not the transcript itself. The document length is short (1526 characters) and it serves as an announcement of the availability of the transcript rather than the transcript content. According to the classification rules, such announcements about the availability of transcripts or reports are classified as Regulatory Filings (RNS) because it is a regulatory announcement and not the full transcript text itself.
2022-10-28 English
In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the transcript of a conference call with analysts and investors on the financial results for the quarter and half year ended 30th September 2022. It references the transcript being placed on the company's website. The document length is short (1526 characters) and it does not contain the transcript itself, only an announcement about the transcript's availability. According to the rules, announcements about transcripts or reports that are short and refer to the report being available elsewhere should be classified as Regulatory Filings (RNS), not as Call Transcript (CT).
2022-10-28 English
In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the audio recording of a conference call with analysts and investors about the financial results for the quarter and half year ended 30th September 2022. It references a previous letter and provides a link to the audio recording on the company's website. The document does not contain the transcript itself, nor detailed financial data or analysis. It is essentially an announcement about the availability of the conference call recording. According to the classification rules, such announcements about conference call recordings are best classified as Regulatory Filings (RNS) because they do not contain the full transcript or substantive financial data, and the document length is short (1494 characters).
2022-10-21 English
Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It encloses detailed related party transactions for the half year ended September 30, 2022. The content includes extensive tabular data on related party transactions, including loans, advances, sales, purchases, remuneration, and guarantees. The document is dated October 21, 2022, and pertains to a half-year period, indicating it is a periodic compliance disclosure rather than a full annual report or audit report. The document is not a brief announcement but contains substantive financial data related to related party transactions for the half year. This fits the category of a Regulatory Filing (RNS) because it is a compliance disclosure under SEBI regulations and does not constitute a full financial report like an Annual Report (10-K) or Interim Report (IR). It is also not a certification or a report publication announcement. Therefore, the best classification is Regulatory Filings (RNS).
2022-10-21 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the audio recording of a conference call with analysts and investors about the financial results for the quarter and half year ended 30th September 2022. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document states that the audio recording has been placed on the company's website, indicating this is an announcement about the availability of the call recording rather than the transcript or the financial report itself. The document length is short (1494 characters), and it does not contain the transcript or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement about the conference call recording, not the call transcript itself or a financial report.
2022-10-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.